Alcidion Group Limited

ALC.ASX

Health Care

Provider of intelligent informatics software for high performance healthcare

Market Data

Price

$0.107

-0.0%
Market Cap

$147.7M

P/E Ratio

38.2x

EPS

$0.003

Div. Yield

0.00%

52-Week Change

-0.1%

Latest Earnings

H1 FY26 Appendix 4D and Half Year Report

26 February 2026

Revenue
$25.50
+44.0% YoY
NPAT
$1.30
EPS
$0.00

Alcidion Group delivered strong H1 FY26 results with revenue surging 44% to $25.5M driven by new contracts including NCIC Mizaic expansion and Leidos deals. The company turned profitable with a $1.3M net profit versus $889k loss in H1 FY25, while underlying EBITDA jumped 675% to a record $4.2M reflecting effective cost control and operational leverage. Key points: Record first half underlying EBITDA of $4.2M (+675%); Strong revenue growth of 44% to $25.5M driven by major contract wins; Turnaround to $1.3M profit from $889k loss in prior period

Recent Announcements

26 Feb 2026 Actual Results Positive

H1 FY26 Appendix 4D and Half Year Report

Alcidion Group delivered strong H1 FY26 results with revenue surging 44% to $25.5M driven by new contracts including NCIC Mizaic expansion and Leidos deals. The company turned profitable with a $1.3M net profit versus $889k loss in H1 FY25, while underlying EBITDA jumped 675% to a record $4.2M reflecting effective cost control and operational leverage. Key points: Record first half underlying EBITDA of $4.2M (+675%); Strong revenue growth of 44% to $25.5M driven by major contract wins; Turnaround to $1.3M profit from $889k loss in prior period

Get real-time alerts for ALC

Receive AI-powered earnings summaries and instant notifications when Alcidion Group Limited releases results.

Register Free